SI-BONE Statistics
Total Valuation
SI-BONE has a market cap or net worth of $637.53 million. The enterprise value is $501.26 million.
| Market Cap | 637.53M |
| Enterprise Value | 501.26M |
Important Dates
The next confirmed earnings date is Monday, May 6, 2024, after market close.
| Earnings Date | May 6, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
SI-BONE has 41.06 million shares outstanding. The number of shares has increased by 12.35% in one year.
| Shares Outstanding | 41.06M |
| Shares Change (YoY) | +12.35% |
| Shares Change (QoQ) | +0.84% |
| Owned by Insiders (%) | 2.39% |
| Owned by Institutions (%) | 98.43% |
| Float | 37.81M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 4.52 |
| Forward PS | 3.77 |
| PB Ratio | 3.71 |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 3.61 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 9.01, with a Debt / Equity ratio of 0.23.
| Current Ratio | 9.01 |
| Quick Ratio | 8.01 |
| Debt / Equity | 0.23 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -11.52 |
Financial Efficiency
Return on equity (ROE) is -28.20% and return on invested capital (ROIC) is -22.52%.
| Return on Equity (ROE) | -28.20% |
| Return on Assets (ROA) | -20.50% |
| Return on Capital (ROIC) | -22.52% |
| Revenue Per Employee | $403,738 |
| Profits Per Employee | -$125,977 |
| Employee Count | 344 |
| Asset Turnover | 0.66 |
| Inventory Turnover | 1.57 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -24.96% in the last 52 weeks. The beta is 1.22, so SI-BONE's price volatility has been higher than the market average.
| Beta (1Y) | 1.22 |
| 52-Week Price Change | -24.96% |
| 50-Day Moving Average | 17.40 |
| 200-Day Moving Average | 19.82 |
| Relative Strength Index (RSI) | 41.18 |
| Average Volume (30 Days) | 425,609 |
Short Selling Information
The latest short interest is 2.44 million, so 5.95% of the outstanding shares have been sold short.
| Short Interest | 2.44M |
| Short Previous Month | 2.53M |
| Short % of Shares Out | 5.95% |
| Short % of Float | 6.46% |
| Short Ratio (days to cover) | 4.65 |
Income Statement
In the last 12 months, SI-BONE had revenue of $138.89 million and -$43.34 million in losses. Loss per share was -$1.13.
| Revenue | 138.89M |
| Gross Profit | 109.42M |
| Operating Income | -46.93M |
| Pretax Income | -43.34M |
| Net Income | -43.34M |
| EBITDA | -34.45M |
| EBIT | -39.87M |
| Loss Per Share | -$1.13 |
Balance Sheet
The company has $166.02 million in cash and $38.99 million in debt, giving a net cash position of $127.03 million or $3.09 per share.
| Cash & Cash Equivalents | 166.02M |
| Total Debt | 38.99M |
| Net Cash | 127.03M |
| Net Cash Per Share | $3.09 |
| Equity / Book Value | 169.38M |
| Book Value Per Share | 4.12 |
| Working Capital | 187.94M |
Cash Flow
In the last 12 months, operating cash flow was -$18.71 million and capital expenditures -$7.80 million, giving a free cash flow of -$26.51 million.
| Operating Cash Flow | -18.71M |
| Capital Expenditures | -7.80M |
| Free Cash Flow | -26.51M |
| FCF Per Share | -$0.69 |
Margins
Gross margin is 78.78%, with operating and profit margins of -33.79% and -31.20%.
| Gross Margin | 78.78% |
| Operating Margin | -33.79% |
| Pretax Margin | -31.20% |
| Profit Margin | -31.20% |
| EBITDA Margin | -24.80% |
| EBIT Margin | -28.71% |
| FCF Margin | -19.09% |
Dividends & Yields
SI-BONE does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -12.35% |
| Shareholder Yield | -12.35% |
| Earnings Yield | -6.90% |
| FCF Yield | -4.22% |
Analyst Forecast
The average price target for SI-BONE is $26.50, which is 70.75% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $26.50 |
| Price Target Difference | 70.75% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 8 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
SI-BONE has an Altman Z-Score of 4.75 and a Piotroski F-Score of 4.
| Altman Z-Score | 4.75 |
| Piotroski F-Score | 4 |